Hepatosplenomegaly, pneumopathy, bone changes and fronto-temporal dementia: Niemann-Pick type B and SQSTM1-associated Paget's disease in the same individual.


Journal

Journal of bone and mineral metabolism
ISSN: 1435-5604
Titre abrégé: J Bone Miner Metab
Pays: Japan
ID NLM: 9436705

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 18 02 2018
accepted: 19 04 2018
pubmed: 28 6 2018
medline: 7 5 2019
entrez: 28 6 2018
Statut: ppublish

Résumé

Data from exome sequencing show that a proportion of individuals in whom a genetic disorder is suspected turn out to have not one, but two to four distinct ones. This may require an evolution in our diagnostic attitude towards individuals with complex disorders. We report a patient with splenomegaly, pneumopathy, bone changes and fronto-temporal dementia (FTD). "Sea-blue histiocytes" in his bone marrow pointed to a lysosomal storage disease. Homozygosity for a pathogenic mutation in the SMPD1 gene confirmed Niemann-Pick disease type B (NPD-B). Mild cognitive impairment and abnormal brain FDG PET were consistent with FTD. We initially tried to fit the skeletal and neurologic phenotype into the NPD-B diagnosis. However, additional studies revealed a pathogenic mutation in the SQSTM1 gene. Thus, our patient had two distinct diseases; NPD-B, and Paget's disease of bone with FTD. The subsequent finding of a mutation in SQSTM1 gene ended our struggle to explain the combination of findings by a singular "unifying" diagnosis and allowed us to make specific therapeutic decisions. SQSTM1 mutations have been reported in association with FTD, possibly because of defective autophagy. Bisphosphonates may be beneficial for PDB, but since they are known to inhibit acid sphingomyelinase activity, we refrained from using them in this patient. While the principle of looking for unifying diagnosis remains valid, physicians should consider the possibility of co-existing multiple diagnoses when clinical features are difficult to explain by a single one. Accurate diagnostic work-up can guide genetic counseling but also lead to better medical management.

Identifiants

pubmed: 29948344
doi: 10.1007/s00774-018-0932-1
pii: 10.1007/s00774-018-0932-1
doi:

Substances chimiques

SQSTM1 protein, human 0
Sequestosome-1 Protein 0

Types de publication

Case Reports Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

378-383

Références

Am J Med Genet. 2002 Apr 15;109(1):42-51
pubmed: 11932991
Br J Radiol. 2002;75 Suppl 1:A2-12
pubmed: 12036828
J Inherit Metab Dis. 2003;26(8):775-85
pubmed: 14739682
Clin Sci (Lond). 2005 Sep;109(3):257-63
pubmed: 16104845
J Inherit Metab Dis. 2005;28(5):733-41
pubmed: 16151905
Pediatrics. 2008 Aug;122(2):e341-9
pubmed: 18625664
J Clin Invest. 1991 Sep;88(3):806-10
pubmed: 1885770
Angew Chem Int Ed Engl. 2009;48(41):7560-3
pubmed: 19746379
Cell Physiol Biochem. 2010;26(1):1-8
pubmed: 20501999
Autophagy. 2012 May 1;8(5):719-30
pubmed: 22647656
Biochim Biophys Acta. 2013 Jan;1831(1):223-7
pubmed: 22691949
J Bone Miner Res. 2012 Jul;27(7):1439-47
pubmed: 22706899
J Inherit Metab Dis. 2013 Jan;36(1):123-7
pubmed: 22718274
Neurology. 2012 Oct 9;79(15):1556-62
pubmed: 22972638
Immunol Invest. 2013;42(7):510-8
pubmed: 24004055
Exp Cell Res. 2014 Jul 1;325(1):27-37
pubmed: 24486447
Cell Death Differ. 2014 Jun;21(6):864-75
pubmed: 24488099
Mol Genet Metab. 2015 Sep-Oct;116(1-2):88-97
pubmed: 26049896
J Cell Biochem. 2016 Feb;117(2):289-99
pubmed: 26212817
J Endocrinol Invest. 2016 Mar;39(3):297-303
pubmed: 26219613
Lung. 2016 Aug;194(4):511-8
pubmed: 27164983
N Engl J Med. 2017 Jan 5;376(1):83-85
pubmed: 27959696
N Engl J Med. 2017 Jan 5;376(1):21-31
pubmed: 27959697
Mol Genet Metab. 2017 Jan - Feb;120(1-2):27-33
pubmed: 28164782
Eur Radiol. 1997;7(3):361-4
pubmed: 9087358

Auteurs

Camelia Voinea (C)

Respiratory Medicine Department, Lausanne University Hospital, Lausanne, Switzerland.

Elena Gonzalez Rodriguez (E)

Service of Endocrinology, Diabetes and Metabolism, Internal Medicine Department, Lausanne University Hospital, Lausanne, Switzerland.

Catherine Beigelman-Aubry (C)

Department of Radiodiagnostic and Interventional Radiology, Lausanne University Hospital, Lausanne, Switzerland.

Victor Leroy (V)

Leenaards Memory Centre, Clinical Neuroscience Department, Lausanne University Hospital, Lausanne, Switzerland.

Bérengère Aubry-Rozier (B)

Service of Endocrinology, Diabetes and Metabolism, Internal Medicine Department, Lausanne University Hospital, Lausanne, Switzerland.

Belinda Campos-Xavier (B)

Division of Genetic Medicine, Lausanne University Hospital, Center for Molecular Diseases, Lausanne, Switzerland.

Diana Ballhausen (D)

Division of Genetic Medicine, Lausanne University Hospital, Center for Molecular Diseases, Lausanne, Switzerland.

Romain Lazor (R)

Respiratory Medicine Department, Lausanne University Hospital, Lausanne, Switzerland.

Frédéric Barbey (F)

Division of Genetic Medicine, Lausanne University Hospital, Center for Molecular Diseases, Lausanne, Switzerland.

Luisa Bonafé (L)

Division of Genetic Medicine, Lausanne University Hospital, Center for Molecular Diseases, Lausanne, Switzerland.

Andrea Superti-Furga (A)

Division of Genetic Medicine, Lausanne University Hospital, Center for Molecular Diseases, Lausanne, Switzerland.

Christel Tran (C)

Division of Genetic Medicine, Lausanne University Hospital, Center for Molecular Diseases, Lausanne, Switzerland. christel.tran@chuv.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH